en

PRODUCT DETAIL

Dasatinib Accord Healthcare 20 mg filmom obalené tablety

Code 7247E
MA number EU/1/24/1839/004
Product Form: tbl flm 60x1x20 mg (blis.OPA/Al/PVC/Al - jednotk.bal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: EU
MAH, country: Accord Healthcare S.L.U, Spain
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA02 Dasatinib
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.07.2024
Validity: 26.07.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.08.2024
eu-flag.png sk-flag.png